Supplier log in
Future Procurement Opportunity (FPO) – Supply of Pharmaceuticals to Community Pharmacies and Health New Zealand Hospitals – 2026/27 Invitation to Tender
Details
| RFx ID : | 35135400 |
| Tender Name : | Future Procurement Opportunity (FPO) – Supply of Pharmaceuticals to Community Pharmacies and Health New Zealand Hospitals – 2026/27 Invitation to Tender |
| Reference # : | A2083196 |
| Open Date : | Q4 2026 |
| Indicative RFx Release Date : | Q4 2026 [?] |
| Tender Type : | Future Procurement Opportunity (FPO) |
| Project Status : | Initial development [?] |
| Indicative Total Value : | $100M + [?] |
| Tender Coverage : | Sole Agency [?] |
| Categories : |
|
| Regions: |
|
| Required Pre-qualifications : | None |
| Contact : |
Pharmac Tender Team tender@pharmac.govt.nz |
Pharmac – Te Pātaka Whaioranga is in the process of finalising its next annual Invitation to Tender (ITT) for the supply of pharmaceuticals to Community Pharmacies and/or Health New Zealand Hospitals.
The Pharmac ITT is an annual open competitive procurement process. It gives suppliers the opportunity to bid for supply of a large range of different medicines and related products (approximately 300–600 line items per tender).
Suppliers bid to have “Principal Supply Status” on medicines and related products included in the annual ITT. If awarded a tender, the supplier’s brand becomes the main funded brand in the community and/or Health New Zealand hospitals. For the 2026/27 ITT, the principal supplier will be guaranteed a minimum volume of the total funded market until 30 June 2030. The minimum volume is usually 95% of the total funded market.
Pharmac consulted on the draft 2026/27 ITT on 30 July 2026, and we will consider all feedback received to inform the final 2026/27 ITT. Find more about this here:
https://www.pharmac.govt.nz/news-and-resources/consultations-and-decisions/consultation-on-the-draft-202627-invitation-to-tender-for-industry
Pharmac generally includes pharmaceuticals in the tender that:
• are currently under a tender agreement, but the principal supply period of the agreement is about to expire
• are coming off patent
• have subsidy or delisting protections that are ending soon
• have new competition.
The finalised annual ITT is released every year in October/November.
Attached to this FPO is information from the Pharmaceutical Schedule that includes detail on when currently active principal supply arrangements are ending. Products where principal supply arrangements are ending soon (e.g., in 2026 or 2027) may be considered for inclusion in this year’s ITT. We welcome supplier enquiries about products they may be interested in supplying.
Other useful links:
Previous annual Invitations to Tender issued:
Final 2025/26 ITT: https://www.pharmac.govt.nz/news-and-resources/consultations-and-decisions/202526-invitation-to-tender
Final 2024/25 ITT: https://www.pharmac.govt.nz/news-and-resources/consultations-and-decisions/202425-invitation-to-tender
Please view the Pharmaceutical Schedule for information on funded pharmaceuticals:
Section B: https://pharmac.govt.nz/pharmaceutical-schedule/community-section-b/
Section H: https://schedule.pharmac.govt.nz/HMLOnline.php
